Zheng MM - Search Results

1

Protein Engineering and Homologous Expression of Serratia marcescens Lipase for Efficient Synthesis of a Pharmaceutically Relevant Chiral Epoxyester.

Chen KC, Zheng MM, Pan J, Li CX, Xu JH. Chen KC, et al. Among authors: zheng mm. Appl Biochem Biotechnol. 2017 Oct;183(2):543-554. doi: 10.1007/s12010-017-2543-z. Epub 2017 Aug 1. Appl Biochem Biotechnol. 2017. PMID: 28766104

2

Enzymatic transformation of vina-ginsenoside R₇ to rare notoginsenoside ST-4 using a new recombinant glycoside hydrolase from Herpetosiphon aurantiacus.

Wang RF, Zheng MM, Cao YD, Li H, Li CX, Xu JH, Wang ZT. Wang RF, et al. Among authors: zheng mm. Appl Microbiol Biotechnol. 2015 Apr;99(8):3433-42. doi: 10.1007/s00253-015-6446-z. Epub 2015 Feb 14. Appl Microbiol Biotechnol. 2015. PMID: 25676336

3

Engineering 7β-Hydroxysteroid Dehydrogenase for Enhanced Ursodeoxycholic Acid Production by Multiobjective Directed Evolution.

Zheng MM, Chen KC, Wang RF, Li H, Li CX, Xu JH. Zheng MM, et al. J Agric Food Chem. 2017 Feb 15;65(6):1178-1185. doi: 10.1021/acs.jafc.6b05428. Epub 2017 Feb 3. J Agric Food Chem. 2017. PMID: 28116898

4

Continuous Production of Ursodeoxycholic Acid by Using Two Cascade Reactors with Co-immobilized Enzymes.

Zheng MM, Chen FF, Li H, Li CX, Xu JH. Zheng MM, et al. Chembiochem. 2018 Feb 16;19(4):347-353. doi: 10.1002/cbic.201700415. Epub 2017 Oct 24. Chembiochem. 2018. PMID: 28926166

5

Progress on ancient DNA investigation of Late Quaternary mammals in China.

Sheng GL, Zheng MM, Xiao B, Yuan JX. Sheng GL, et al. Among authors: zheng mm. Yi Chuan. 2025 Jan;47(1):46-57. doi: 10.16288/j.yczz.24-193. Yi Chuan. 2025. PMID: 39791298 Review.

6

Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis.

Li YK, Ge FJ, Liu XN, Zeng CM, Qian MJ, Li YH, Zheng MM, Qu JJ, Fang LJ, Lu JJ, Yang B, He QJ, Zhou JY, Zhu H. Li YK, et al. Among authors: zheng mm. Acta Pharmacol Sin. 2024 Dec 3. doi: 10.1038/s41401-024-01427-0. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39627385

7

Proteolethargy is a pathogenic mechanism in chronic disease.

Dall'Agnese A, Zheng MM, Moreno S, Platt JM, Hoang AT, Kannan D, Dall'Agnese G, Overholt KJ, Sagi I, Hannett NM, Erb H, Corradin O, Chakraborty AK, Lee TI, Young RA. Dall'Agnese A, et al. Among authors: zheng mm. Cell. 2025 Jan 9;188(1):207-221.e30. doi: 10.1016/j.cell.2024.10.051. Epub 2024 Nov 27. Cell. 2025. PMID: 39610243

8

IMPDH inhibitors upregulate PD-L1 in cancer cells without impairing immune checkpoint inhibitor efficacy.

Zheng MM, Li JY, Guo HJ, Zhang J, Wang LS, Jiang KF, Wu HH, He QJ, Ding L, Yang B. Zheng MM, et al. Acta Pharmacol Sin. 2024 Nov 26. doi: 10.1038/s41401-024-01411-8. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39592732

9

Comparative proteomic analysis between tumor tissues and intratumoral exosomes from lung adenocarcinoma patients identifies PAFAH1B3 as an exosomal protein key for initiating metastasis in lung adenocarcinoma.

Wang C, Xiao L, Gao L, Wu J, Wang S, Zheng MM, Qin CT, Huang XG, Zhou L, Xu WJ, Li HG, Chen WL, Zhu LH, Jin X. Wang C, et al. Among authors: zheng mm. Heliyon. 2024 Oct 28;10(21):e39859. doi: 10.1016/j.heliyon.2024.e39859. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39553628 Free PMC article.

10

Active RNA synthesis patterns nuclear condensates.

Banani SF, Goychuk A, Natarajan P, Zheng MM, Dall'Agnese G, Henninger JE, Kardar M, Young RA, Chakraborty AK. Banani SF, et al. Among authors: zheng mm. bioRxiv [Preprint]. 2024 Oct 13:2024.10.12.614958. doi: 10.1101/2024.10.12.614958. bioRxiv. 2024. PMID: 39498261 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters